Leuven Growing Into Deficit Follow-up Study
Completed
- Conditions
- ChildHeart Defects, CongenitalMental ProcessesCritical Illness
- Registration Number
- NCT01632813
- Lead Sponsor
- KU Leuven
- Brief Summary
The key objective of the Leuven growing-into-deficit (GID) follow-up-study is to test the hypothesis that children with a congenital heart disease (CHD) show more neurocognitive impairment at the second follow-up at 7 years old than at the first follow-up at the age of 4, compared to healthy controls.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 172
Inclusion Criteria
- Seven-year-old children with CHD and healthy control children who were four years old when they participated in Paediatric ICU follow-up study (i.e. first follow-up time point) (Neurocognitive development of children four years after critical illness and treatment with tight glucose control, Clinical Trials # NCT00214916). The children of the CHD-group underwent cardiac surgery as infants (=<1year).
Exclusion Criteria
- Genetic syndromes (Down, 22q11del), known to result in neurocognitive impairment
- IQ < 70
- Lack of baseline neurocognitive measurements during first follow-up
- Date of birth before February 2005
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method reaction time (RT) and error rates of inhibitory control (Response Organization Objects, ROO) (Amsterdam Neuropsychological Tasks, ANT) one testpoint at age of 7 years
- Secondary Outcome Measures
Name Time Method Number of taps on computerized tapping tasks (ANT) one testpoint at age of 7 years IQ measures (Revised Wechsler Preschool and Primary Scale of Intelligence, WPPSI-R) one testpoint at age of 7 years Visual-Motor Integration total standard score (VMI) one testpoint at age of 7 years Child Behavior CheckList T-scores for internalizing and externalizing problems one testpoint at age of 7 years Pediatric Quality of Life Inventory - Generic Score Scales (PedsQL) to quantify quality of life one testpoint at age of 7 years reaction time (RT) and error rates of cognitive flexibility (ROO, ANT) and working memory (Memory Search - Objects 2 Keys, ANT) one testpoint at age of 7 years Mean RT + standard deviation (SD) of RT on computerized alertness task (Baseline Speed, ANT) one testpoint at age of 7 years Behavior Rating Inventory of Executive Function (BRIEF) to measure executive functions (parent and teacher version) one testpoint at age of 7 years Teacher Report Form (TRF) T-scores for internalizing and externalizing problems at school one testpoint at age of 7 years Incidence of medical problems (e.g. head trauma), interventions and operations since first follow-up one testpoint at age of 7 years
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie neurocognitive deficits in children with congenital heart disease as studied in NCT01632813?
How does the neurocognitive development trajectory in CHD patients compare to standard-of-care outcomes in longitudinal studies?
Are there specific biomarkers associated with neurocognitive impairment progression in congenital heart disease cases?
What adverse events are commonly reported in CHD children during early neurodevelopmental follow-ups and how are they managed?
How do combination therapies for congenital heart defects impact long-term neurocognitive outcomes in pediatric populations?
Trial Locations
- Locations (1)
Dept Intensive Care Medicine
🇧🇪Leuven, Vlaams Brabant, Belgium
Dept Intensive Care Medicine🇧🇪Leuven, Vlaams Brabant, Belgium